Download Free Medical Gastroparesis PowerPoint Presentation

Gastroparesis PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : Check out this medical PowerPoint presentation titled "GASTROPARESIS” by Dr. Mohit Bhatia.

This medical PowerPoint presentation talks about gastroparesis, a condition in which the stomach muscles are unable to properly contract and empty food from the stomach into the small intestine. This can cause food to remain in the stomach for an extended period of time, leading to various symptoms such as nausea, vomiting, bloating, abdominal pain, and a feeling of fullness even after eating a small amount.

There are several underlying causes of gastroparesis, including diabetes, neurological disorders, medication side effects, and surgery involving the stomach or small intestine. The diagnosis is usually made through a combination of medical history, physical examination, and various tests such as gastric emptying studies and endoscopy.

Tags : Gastroparesis, diabetes, neurological disorders, Gastroenterology, Gastroenterology PowerPoint presentation

Published on : Apr 26, 2023 | Views : 1371 | Downloads : 1

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

GASTROPARESIS Arnold Wald, M.D., AGA-F University of Wisconsin School of Medicine & Public Health, Madison, WI
Slide 2-

MAIN FUNCTIONS OF STOMACH I. PROXIMAL Functions: Accommodation Storage of ingested food Regulation of intragastric pressure Tonic movement of chyme Motor Pattern: Tonic activity DISTAL Functions: Grinding of food Emptying to duodenum Motor Pattern: Phasic activity
Slide 3-

B3 Pacemaker region Corpus Fundus Antrum Pylorus Pacemaker potentials determine contractile parameters Contractile parameters Max frequency (3/min) Propagation velocity Propagation direction Motility of the Antral Pump Is Initiated by a Dominant Pacemaker in the Mid-corpus The antral pump is formed by the mid and distal corpus, antrum, and pylorus Pacemaker potential B87
Slide 4-

B4 % Meal remaining in stomach Lag phase Emptying phase Onset and Rate of Gastric Emptying Varies With the Composition of the Meal Time after meal (min) Solid meal Liquid meal 100 75 50 25 0 20 0 60 40 100 80 Semisolid meal
Slide 5-

Gastric emptying – evolving concepts Relationship with symptoms unclear NOT nausea, vomiting or pain Accelerating gastric emptying does not necessarily improve symptoms Symptomatic improvement including weight gain is possible without improving gastric emptying Gastroparesis is frequently overdiagnosed on the basis of outdated emptying tests
Slide 6-

Causes of Gastroparesis Idiopathic 36% Diabetic 29% Upper GI surgery 13% Parkinson’s 8% Collagen tissue disorder 5% Intestinal pseudo-obstruction 4% Miscellaneous (Incl eating disorders) 6% Soykan et al, DDS 1998; 43:2398-2404
Slide 7-

Drugs that delay gastric emptying(Partial listing) β Agonists Anticholinergics Tricyclic agents Phenothiazines Dopamine agonists Opiates Proton pump inhibitors Miscellaneous Dexfenfluramine Antihistamines Lithium Tetrahydrocannabinol Tobacco
Slide 8-

Workup for suspected gastroparesis UGI Series: Excludes mechanical obstruction Retention of barium w/o obstruction is diagnostic Endoscopy: Bezoar without obstruction highly suggestive Gastric Emptying: Solids more sensitive than liquids
Slide 9-

Normal values for low fat, egg white GES Lower normal limit Upper normal limit Time for gastric retention* for gastric retention** 0.5 hr. 70% 1.0 hr. 30% 90% 2.0 hr. 60% 4.0 hr. 10% * Lower value suggests rapid emptying ** Higher values suggest delayed emptying Am J Gastroenterol 2008
Slide 10-

2. A 30 y.o. woman with a one year history of type II diabetes mellitus presents with nausea and early satiety. Her blood sugars have been erratic and her last HBAIC was 9.2. Endoscopy was normal and a gastric emptying test showed 20% retention of the meal at 4 hours (normal < 10%). Which of the following would you recommend: a) Metoclopramide b) Rigorous control of blood sugars c) Erythromycin d) Botulinum toxin injection of the pylorus
Slide 11-

Slow gastric emptying was frequent in women with type 2 diabetes with hyperglycemia and normalized after diabetic control J Diabetes & Complications, 2013
Slide 12-

2. A 23 y.o. woman developed a viral illness associated with fever, myalgias, nausea, vomiting and diarrhea. Although most of her symptoms resolved over 2 weeks, she continued to have nausea, occasional retentive vomiting, early satiety and a 10 lb. weight loss. Endoscopy showed a modest amount of retained food in the stomach and a gastric retention of a test meal consisting of egg whites, toast and jam at 4 hours was 35% (normal <10%). Which of the following would you recommend first? a) Metoclopramide b) Botulinum toxin injection (pylorus) c) Erythromycin d) Gastric stimulator
Slide 13-

Management of Gastroparesis Dietary Modifications Small frequent (6/day) meals Reduced fat (<40 gm/day) Soup, crackers, noodles, pasta, potatoes, rice, cheese Reduced fiber  helps avoid bezoar Liquid caloric supplementation
Slide 14-

Prokinetic Agents ACh-esterase inhibitors: pyridostigmine Motilides: erythromycin Antidopamine agents: domperidone* Antidopamine/serotonin agents: metoclopramide Serotonin agents: tegaserod*, prucalopride* *Not available in USA
Slide 15-

ERYTHROMYCIN Motilin agonist No antiemetic effect Stimulates antral contractions (IV >> PO) Stimulates MMC Dose: 125-250 mg bid/tid (PO) 3 mg/kg q 8 hours (IV)
Slide 16-

Metoclopramide Central/peripheral D2 antagonist and 5 HT agonist Increases antral contractions Decreases fundal relaxation Improves antroduodenal coordination Dose: 5-20 mg qid (PO, IV, SQ, SL)
Slide 17-

Metoclopramide 30% of patients experience side effects 10% have neurologic side effects Parkinson-type syndrome Tardive dyskinesia Hyperprolactinemia * Boxed Warning for chronic use issued by FDA*
Slide 18-

Domperidone Peripheral D2 antagonist Increases antral contractions Decreases fundal relaxation Improves antroduodenal coordination Dose: 10-30 mg qid (PO) Limited availability in USA
Slide 19-

Efficacy of Domperidone in Diabetic Gastroparesis □ Improved symptoms in 64% □ Improved gastric emptying in 60% □ Reduced hospital admission in 67% □ 28 trials (19 double arm); 1016 patients Sugumar A et al, CGH 2008
Slide 20-

Effects of Botulinum Toxin on GE and GI Symptoms Friedenberg FK, et al. Am J Gastro 2008
Slide 21-

3. A 28 y.o. man with IDDM is referred for chronic and recurrent nausea and vomiting. He reports 3-4 episodes yearly for the past 5 years with frequent ED visits or hospitalizations lasting 3-4 days. Between episodes, he feels well and has lost no weight. During these episodes, he finds great relief when taking hot showers. The most appropriate intervention for this patient is: a) Domperidone 20 mg AC meals b) Nortriptyline in doses up to 100mg hs c) Discontinue smoking marijuana d) Strict control of blood sugars; metoclopramide 10 mg SQ during episodes
Slide 22-

Cyclic Vomiting Syndrome Recurrent and stereotypical episodes of severe nausea and vomiting separated by symptom free intervals - Gastric emptying rapid or normal - Maintenance of weight
Slide 23-

Cannabinoid Hyperemesis - Cyclic vomiting syndrome - Compulsive hot water bathing - Poor response to TCAs
Slide 24-

Cyclic Vomiting in Adults(Non-Cannabinoid) Association with migraine headaches Psychological disorders (anxiety/depression) Absence of compulsive hot water bathing Often responds to TCAs
Slide 25-

References 1. Hasler WL. Gastroparesis: pathogenesis, diagnosis and management. Nat Rev Gastroenterol Hepatol 2011;8:438-53. 2. Choung RS et al. Cyclic vomiting syndrome and functional vomiting in adults. Neurogastroenterol Motil 2011;24:20-26